Weinstein Boaz

10% Ownerabrdn Life Sciences Investors (HQL) · full profile →Form 4 · filed May 31, 2024
Net Buying
Open-Market Buys
$623K
Open-Market Sells
$0
Net Open-Market Flow
$623K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 30, 2024Buy(P)669$13.05$9K3.3M
May 29, 2024Buy(P)38K$13.09$498K3.3M
May 28, 2024Buy(P)9K$13.38$117K3.3M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001510281-24-000312) within minutes of acceptance. Every field above traces to the original document. Verify it directly: